Bulked-Up Glooko To Launch 'Unified' Diabetes Offering Next Year
Executive Summary
Glooko and Diasend, two specialists in software solutions for diabetes management, have merged. With a new cash injection of $8m from venture investors, the combined company expects to launch its first product that brings together each entity's know-how next year.
You may also be interested in...
mHealth Developer Works Around Traditional Reimbursement Barriers
Glooko says it has found more success by pitching its diabetes management app to self-insured employers and to payers as a tool they can implement to reduce spending, rather than by pursuing reimbursement the traditional way. It's one model for the digital-health sector in the current health-care environment.
Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roche Dx' EMEA Head To Take Charge After Diggelmann Departs
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.